The Effects of Physiotherapy in Migraine
The Effects of Physiotherapy Applications in Individuals With Migraine
The aim of this study is to investigate the effects of a physiotherapy program including cervical muscle training and transcutaneous auricular vagus nerve stimulation (taVNS) on pain, functional status, quality of life, psychological status, and sleep quality in individuals with migraine.
Studieoversigt
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
Ankara, Tyrkiet (Türkiye), 06560
- Rekruttering
- Gazi Mustafa Kemal Occupational and Environmental Diseases Hospital
-
Kontakt:
- Nuriye Kayalı Şendur
- Telefonnummer: +90 312 212 66 66
- E-mail: ankaradhs7@saglik.gov.tr
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Volunteering to participate in the study
- Being between 18 and 55 years of age
- Being diagnosed with migraine by a neurologist according to the International Classification of Headache Disorders 3 (ICHD-3) criteria
Exclusion Criteria:
- Diagnosis of other primary and/or secondary headaches in addition to migraine,
- Coexisting neurological and/or rheumatological diseases,
- Severe psychiatric disorders (bipolar disorder, schizophrenia, psychosis, etc.),
- Pregnancy or lactation,
- Malignancy,
- Known arrhythmia or presence of any implanted electronic device,
- Presence of sensory loss in the application area,
- Having received physiotherapy or any other treatment in the head/neck region within the last 12 months,
- History of head/neck trauma or surgery within the last 12 months.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Ingen indgriben: Control Group
The control group will receive no intervention and will continue with their routine treatment. |
|
|
Eksperimentel: Treatment Group
In addition to routine treatments, a physiotherapy program including transcutaneous auricular vagus nerve stimulation and cervical muscle exercises will be implemented. |
A physiotherapy program including taVNS and cervical muscle exercises |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Pain Assessment
Tidsramme: Baseline, 8th week (after treatment)
|
Individuals' pain parameters will be assessed using a pain diary. |
Baseline, 8th week (after treatment)
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Assessment of Functional Status
Tidsramme: Baseline, 8th week (after treatment)
|
The Migraine Disability Assessment Scale will be used to determine the functional status associated with migraine. This scale aims to evaluate headache-related disability and the functionality of individuals diagnosed with migraine in daily and social activities. Score ranges are calculated as follows: Grade I: no loss or very little loss (0-5 days); Grade II: mild loss (6-10 days); Grade III: moderate loss (11-20 days); Grade IV: severe loss (21 days or more) |
Baseline, 8th week (after treatment)
|
|
Quality of Life Assessment
Tidsramme: Baseline, 8th week (after treatment)
|
The Migraine-Specific Quality of Life Scale (Version 2.1) will be used to assess quality of life. The 14-item scale comprises three sections: role-limiting, role-preventing, and emotional function. Scores for each subsection range from 0 to 100. Higher scores indicate better health-related quality of life. |
Baseline, 8th week (after treatment)
|
|
Assessment of Psychological State
Tidsramme: Baseline, 8th week (after treatment)
|
The Hospital Anxiety and Depression Scale will be used to assess psychological status. Of the 14 items comprising the scale, the 7 odd-numbered items assess anxiety disorder, while the 7 even-numbered items assess depression. The minimum and maximum scores patients can obtain on either subscale are 0 and 21, respectively. Higher scores indicate higher levels of depression and anxiety. |
Baseline, 8th week (after treatment)
|
|
Sleep Quality Assessment
Tidsramme: Baseline, 8th week (after treatment)
|
The Single-Item Sleep Quality Scale will be used to assess sleep quality.In this scale, participants are asked the question, "How would you rate your sleep quality overall over the past 7 days?" Responses are obtained using a numerical rating ranging from 0 (Terrible) to 10 (Excellent) . |
Baseline, 8th week (after treatment)
|
Samarbejdspartnere og efterforskere
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- AYBU-2026-05
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .